RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902

Chen, Binshen; Xu, Kai; Zhang, Yiming; Xu, Peng; Li, Chaoming; Liu, Jun; Xu, Yawen

doi:10.3390/cancers18081229

Open AccessRetraction

RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902

by

Binshen Chen

^1,2,†

,

Kai Xu

^1,2,†,

Yiming Zhang

^1,2,†,

Peng Xu

^1,2,

Chaoming Li

^1,2,

Jun Liu

^1,2 and

Yawen Xu

^1,2,*

¹

Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China

²

Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, China

^*

Author to whom correspondence should be addressed.

^†

These authors contributed equally to this work.

Cancers 2026, 18(8), 1229; https://doi.org/10.3390/cancers18081229

Submission received: 8 April 2026 / Accepted: 8 April 2026 / Published: 13 April 2026

(This article belongs to the Section Cancer Therapy)

Download Versions Notes

The journal retracts the article titled “LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation Through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway” [1], cited above.

Following publication, concerns were brought to the attention of the Editorial Office regarding the integrity of a figure published in this article [1].

In accordance with standard journal procedures, the Editorial Office and Editorial Board conducted an investigation that confirmed an overlap between Figure 7G in [1] and Figure 2F in a previously published article [2], produced by a different research group and presenting different experimental conditions. Although the authors cooperated with the investigation, the explanations and supporting materials provided were not deemed sufficient by the Editorial Board to resolve the identified concerns. As a result, the Editorial Board has lost confidence in the reliability of the findings, and has decided to retract this publication, as per MDPI’s retraction policy.

This retraction was approved by the Editor-in-Chief of the journal Cancers.

The authors have been informed of this retraction but did not provide a comment on this decision.

References

Chen, B.; Xu, K.; Zhang, Y.; Xu, P.; Li, C.; Liu, J.; Xu, Y. RETRACTED: LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902. [Google Scholar] [CrossRef] [PubMed]
Wang, X.; Zhu, M.; Zuo, H.; Hou, G.; Xie, R. ADAM Metallopeptidase Domain 12 Facilitates Colorectal Cancer Progression by Inhibiting Hippo Signaling Pathway Activity. Mol. Cancer Res. 2023, 21, 525–534. [Google Scholar] [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chen, B.; Xu, K.; Zhang, Y.; Xu, P.; Li, C.; Liu, J.; Xu, Y. RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902. Cancers 2026, 18, 1229. https://doi.org/10.3390/cancers18081229

AMA Style

Chen B, Xu K, Zhang Y, Xu P, Li C, Liu J, Xu Y. RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902. Cancers. 2026; 18(8):1229. https://doi.org/10.3390/cancers18081229

Chicago/Turabian Style

Chen, Binshen, Kai Xu, Yiming Zhang, Peng Xu, Chaoming Li, Jun Liu, and Yawen Xu. 2026. "RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902" Cancers 18, no. 8: 1229. https://doi.org/10.3390/cancers18081229

APA Style

Chen, B., Xu, K., Zhang, Y., Xu, P., Li, C., Liu, J., & Xu, Y. (2026). RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902. Cancers, 18(8), 1229. https://doi.org/10.3390/cancers18081229

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

RETRACTED: Chen et al. LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway. Cancers 2023, 15, 1902

References

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI